Executive Summary
Eco Science Solutions Inc (ESSI) reported QQ2 2026 results with no revenue disclosed in the provided data, accompanied by an operating expenditure build that produced a net loss of $262,843 and an earnings per share of -$0.005. R&D expense totaled $80,053, with operating expenses of $242,898 and other expenses of $162,845, contributing to the bottom-line shortfall. Net income declined appears to be driven by a burn-focused cost structure rather than top-line growth, as revenue figures were not disclosed in the quarter.
From a liquidity and balance-sheet perspective, ESSI exhibits meaningful stress. Cash on hand was $3,098 at quarter-end, while short-term debt stood at $7,075,663 and total current liabilities were $17,203,119. Total assets reported were $104,583, with total stockholders’ equity of -$17,098,536, indicating negative book value and a high reliance on external financing to fund operations. Operating cash flow was negative at -$91,889, with financing activities contributing $93,288 and resulting in a modest net cash increase of $1,399 for the period. Net debt stood at approximately $7.07 million, underscoring a fragile liquidity position for ESSI unless revenue generation or additional financing materializes.
Given the absence of disclosed revenue and the balance-sheet fragility, ESSI remains a high-risk, high-uncertainty investment. The near-term trajectory will hinge on monetization of the Herbo platform and any forthcoming licensing or enterprise deals, along with the company’s ability to manage burn and secure sustainable capital. Investors should closely monitor topline progress, cost discipline, and any management guidance on revenue milestones, financing plans, and liquidity runway.
Key Performance Indicators
Key Insights
Revenue: Not disclosed for QQ2 2026 (data field is null). Net Income: -$262,843 for QQ2 2026; YoY net income: 10.78% (as per provided earnings metrics); QoQ net income: 3.87% (as per provided earnings metrics). EPS: -$0.005 for QQ2 2026; YoY EPS: 10.71%; QoQ EPS: 50.00%. Operating Cash Flow: -$91,889; Free Cash Flow: -$91,89 (stated as -$91,889 in the data). Cash and equivalents: $3,098 at period end; Net debt: $7,072,565. Short-term debt: $7,075,663. Total current liabilities: $17,203,119. Tota...
Financial Highlights
Revenue: Not disclosed for QQ2 2026 (data field is null). Net Income: -$262,843 for QQ2 2026; YoY net income: 10.78% (as per provided earnings metrics); QoQ net income: 3.87% (as per provided earnings metrics). EPS: -$0.005 for QQ2 2026; YoY EPS: 10.71%; QoQ EPS: 50.00%. Operating Cash Flow: -$91,889; Free Cash Flow: -$91,89 (stated as -$91,889 in the data). Cash and equivalents: $3,098 at period end; Net debt: $7,072,565. Short-term debt: $7,075,663. Total current liabilities: $17,203,119. Total assets: $104,583. Intangible assets: $100,000. Goodwill: 0. Net working capital metrics are heavily negative given current liabilities dwarf current assets (in the provided data).
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Net Income |
-262.84K |
10.78% |
3.87% |
| EPS |
-0.01 |
10.71% |
50.00% |
Management Commentary
Transcript data not included in the provided materials. Unable to extract management quotes or themes from an earnings call without the transcript text. Please provide the earnings call transcript or a link to enable theme-based highlights and quote extraction.
Forward Guidance
No explicit forward guidance is present in the supplied data. In the absence of revenue, ESSI’s near-term trajectory hinges on monetization of the Herbo enterprise software suite and the company’s ability to secure licensing or enterprise deals within the cannabis and CBD/hemp ecosystem. Suggested focal points for investors include: (1) any management guidance on revenue milestones, customer adoption timelines, and gross margins; (2) expected trajectory of operating expenses and dollar burn rate; (3) financing plans (equity or debt) and dilution risk; (4) cash runway given current liquidity and debt levels. Realistic assessment suggests a cautious view until tangible topline progress or credible capital-raising measures are disclosed. Key catalysts would include a definite monetization plan, binding customer commitments, or strategic partnerships that improve revenue visibility.